| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | | Total Revenue |
-
|
-
| | Cost of Revenue | 368 | 1,008 | | | Gross Profit | (368) | (1,008) | | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 5,081 | 5,902 | | Non Recurring |
-
|
-
| | Others | 64 | 44 | | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | (5,513) | (6,954) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (10,198) | (8,559) | | Earnings Before Interest And Taxes | (15,711) | (7,445) | | Interest Expense | 32 |
-
| | Income Before Tax | (15,743) | (7,445) | | Income Tax Expense |
-
|
-
| | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | (15,743) | (15,513) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | (15,743) | (15,513) | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | ($15,743) | ($15,513) |
|
0.29% Nasdaq 
Income Statement
